Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 46, Issue 9, Pages 2078-2090
Publisher
Wiley
Online
2016-07-28
DOI
10.1002/eji.201646485
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant
- (2016) Ivan Jelcic et al. ANNALS OF NEUROLOGY
- Novel Agents for Relapsing Forms of Multiple Sclerosis
- (2016) Rebecca Straus Farber et al. Annual Review of Medicine
- Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
- (2016) Harold L Atkins et al. LANCET
- Fingolimod-associated PML in a patient with prior immunosuppression
- (2016) Tirisham V. Gyang et al. NEUROLOGY
- Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation
- (2016) Catharina C. Gross et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease
- (2016) Anne-Christine Flach et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Role of T Cells in CNS Homeostasis
- (2016) Erik Ellwardt et al. TRENDS IN IMMUNOLOGY
- Type I/II Interferon Balance in the Regulation of Brain Physiology and Pathology
- (2016) Aleksandra Deczkowska et al. TRENDS IN IMMUNOLOGY
- Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
- (2015) Josa M. Frischer et al. ANNALS OF NEUROLOGY
- Neurons and T cells: Understanding this interaction for inflammatory neurological diseases
- (2015) Lidia Yshii et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
- (2015) Aleksanteri Aspelund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis
- (2015) N. Pfender et al. NEUROLOGY
- Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial
- (2015) G. L. Mancardi et al. NEUROLOGY
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate
- (2015) Thorsten Rosenkranz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
- (2015) Yonghao Cao et al. Science Translational Medicine
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- (2014) Amit Bar-Or et al. DRUGS
- B cells in Multiple Sclerosis: Good or bad guys?
- (2014) Franziska Hoffmann et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- An update on the biology of sphingosine 1-phosphate receptors
- (2014) Victoria A. Blaho et al. JOURNAL OF LIPID RESEARCH
- Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging
- (2014) Olga Ciccarelli et al. LANCET NEUROLOGY
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
- (2014) Felix J. Hartmann et al. Nature Communications
- Immunophenotyping of Cerebrospinal Fluid Cells in Multiple Sclerosis
- (2014) Sascha Alvermann et al. JAMA Neurology
- Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
- (2013) Sofia V. Abrahamsson et al. BRAIN
- Progressive multifocal leukoencephalopathy in patients with multiple sclerosis
- (2013) Kelly J. Baldwin et al. CURRENT OPINION IN NEUROLOGY
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- T-cell response against varicella-zoster virus in fingolimod-treated MS patients
- (2013) M. E. Ricklin et al. NEUROLOGY
- Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
- (2012) Christina Elliott et al. BRAIN
- IL-23: One cytokine in control of autoimmunity
- (2012) Andrew L. Croxford et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis
- (2012) J. A. Quandt et al. JOURNAL OF IMMUNOLOGY
- Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
- (2012) Rajneesh Srivastava et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis
- (2012) J. S. A. Perry et al. Science Translational Medicine
- Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome
- (2011) Lilian Aly et al. BRAIN
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
- (2011) Raquel Planas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The molecular basis of neurodegeneration in multiple sclerosis
- (2011) Hans Lassmann et al. FEBS LETTERS
- Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
- (2011) Kamran Ghoreschi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
- (2011) Alasdair J Coles et al. LANCET NEUROLOGY
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
- (2011) M. Cossburn et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine networks in multiple sclerosis: lost in translation
- (2010) Laura Codarri et al. CURRENT OPINION IN NEUROLOGY
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies
- (2009) Eugene O. Major Annual Review of Medicine
- EAE: An immunologist's magic eye
- (2009) Gurumoorthy Krishnamoorthy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interferon- mechanisms of action in multiple sclerosis
- (2009) S. Dhib-Jalbut et al. NEUROLOGY
- Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals
- (2009) T. Derfuss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction
- (2009) Britta Engelhardt et al. Seminars in Immunopathology
- IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
- (2008) Mark A. Kroenke et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Perivascular Spaces and the Two Steps to Neuroinflammation
- (2008) Trevor Owens et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- Autologous haematopoietic stem-cell transplantation in multiple sclerosis
- (2008) Gianluigi Mancardi et al. LANCET NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search